NYSE · SIC 8090
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients. The company provides acute inpatient dialysis. services in approximately 850 hospitals and related laboratory services.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $11.6B | $11.6B | $11.6B | $12.1B | $12.8B | $13.6B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $1.7B | $1.8B | $1.3B | $1.6B | $2.1B | $2.0B |
| Net income | $773.6M | $1.2B | $781.6M | $957.0M | $1.3B | $1.1B |
| Diluted EPS | $6.31 | $8.90 | $5.85 | $7.42 | $10.73 | $9.84 |
| Operating cash flow | $2.0B | $1.9B | $1.6B | $2.1B | $2.0B | $1.9B |
| Free cash flow | $1.3B | $1.3B | $961.1M | $1.5B | $1.5B | $1.3B |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 14.7% | 15.5% | 11.5% | 13.2% | 16.3% | 15.0% |
| Net margin | 6.7% | 10.4% | 6.7% | 7.9% | 9.8% | 7.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.3B | $3.3B | $3.2B | $3.4B | $3.4B | $3.6B | $3.4B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $506.4M | $534.9M | $565.4M | $438.9M | $537.8M | $505.8M | $561.1M | $481.9M |
| Net income | $222.7M | $214.7M | $573.7M | $162.9M | $199.3M | $150.3M | $566.1M | $197.5M |
| Diluted EPS | $2.50 | $2.50 | $3.08 | $2.00 | $2.58 | $2.04 | $3.22 | $2.87 |
| Operating cash flow | $798.8M | $810.4M | $547.6M | $180.0M | $324.2M | $841.5M | $540.7M | $320.8M |
| Free cash flow | $674.1M | $671.4M | $377.0M | $36.8M | $203.1M | $675.4M | $395.3M | $218.8M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 15.9% | 16.4% | 17.2% | 13.6% | 15.9% | 14.8% | 15.5% | 14.1% |
| Net margin | 7.0% | 6.6% | 17.4% | 5.1% | 5.9% | 4.4% | 15.6% | 5.8% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-16 | Rodriguez Javier· Chief Executive Officer | Sale | 39,407 | $209.28 | $8.2M | filing |
| 2026-06-15 | Rodriguez Javier· Chief Executive Officer | Sale | 30,000 | $209.50 | $6.3M | filing |
| 2026-06-15 | Waters Kathleen Alyce· Chief Legal & Pub. Affairs Off | Sale | 8,950 | $207.84 | $1.9M | filing |
| 2026-06-15 | Waters Kathleen Alyce· Chief Legal & Pub. Affairs Off | Sale | 6,455 | $209.17 | $1.4M | filing |
| 2026-05-26 | YALE PHYLLIS R | Gift | 5,038 | $0.00 | $0.00 | filing |
| 2026-05-15 | HEARTY JAMES O· Chief Compliance Officer | Sale | 15,000 | $193.98 | $2.9M | filing |
| 2026-05-15 | Schoppert Wendy Lee | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-15 | Moore Gregory J. | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-15 | Pullin Dennis W | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-15 | Schechter Adam H | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-15 | DESOER BARBARA J | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-15 | Hollar Jason M. | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-15 | YALE PHYLLIS R | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-15 | Arway Pamela M | Award | 250 | $0.00 | $0.00 | filing |
| 2026-05-14 | HEARTY JAMES O· Chief Compliance Officer | D | 3,231 | $198.10 | $640,061.10 | filing |
| 2026-05-14 | HEARTY JAMES O· Chief Compliance Officer | Option exercise | 5,784 | $110.63 | $639,883.92 | filing |
| 2026-05-14 | HEARTY JAMES O· Chief Compliance Officer | Tax withholding | 1,117 | $198.10 | $221,277.70 | filing |
| 2026-05-12 | Maughan David Paul· Chief Operating Officer, DKC | Sale | 13,456 | $199.25 | $2.7M | filing |
| 2026-05-11 | Maughan David Paul· Chief Operating Officer, DKC | Sale | 7,073 | $199.15 | $1.4M | filing |
| 2026-05-07 | ACKERMAN JOEL· CFO and Treasurer | Sale | 51,471 | $192.10 | $9.9M | filing |
| 2026-05-06 | HEARTY JAMES O· Chief Compliance Officer | Sale | 2,184 | $174.87 | $381,916.08 | filing |
| 2026-05-01 | BERKSHIRE HATHAWAY INC | Sale | 1,220,376 | $149.84 | $182.9M | filing |
| 2026-03-15 | ACKERMAN JOEL· CFO and Treasurer | Tax withholding | 33,693 | $150.72 | $5.1M | filing |
| 2026-03-15 | Waters Kathleen Alyce· Chief Legal & Pub. Affairs Off | Tax withholding | 26,118 | $150.72 | $3.9M | filing |
| 2026-03-15 | HEARTY JAMES O· Chief Compliance Officer | Tax withholding | 8,984 | $150.72 | $1.4M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.